Recurring Revenue MixPHC combines capital equipment with recurring consumables across diagnostics, life‑sciences and medical segments. Installed‑base consumable and service demand creates predictable after‑sales revenue, supporting steady cash flow and margin resilience over multiple quarters.
Cash GenerationOperating cash flow has been consistently positive and free cash flow remained positive even during loss years, with material improvement since 2023. Reliable cash conversion supports internal funding for capex, working capital, dividends or debt reduction without sole reliance on markets.
Improving LeverageLeverage has meaningfully declined and equity has rebuilt, improving balance‑sheet resilience. Reduced debt ratios lower refinancing stress and interest burden, giving management more flexibility to invest in R&D, sustain service networks and gradually strengthen the capital structure.